Cargando…
Label-free quantitative proteomic analysis of serum exosomes from patients of renal anemia: The Good and the Bad of Roxadustat
BACKGROUND: Roxadustat is a new oral anti-renal anemia medication that works by stabilizing hypoxia-inducible factor (HIF) which can activate the expression of more than 100 genes in addition to genes related to anemia. However, the more potential molecular targets of roxadustat are not completely c...
Autores principales: | You, Xiaoe, Guo, Baochun, Wang, Zhen, Ma, Hualin, Zhang, Xinzhou |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9187900/ https://www.ncbi.nlm.nih.gov/pubmed/35690731 http://dx.doi.org/10.1186/s12014-022-09358-w |
Ejemplares similares
-
Case Report: Roxadustat in Combination With Rituximab Was Used to Treat EPO-Induced Pure Red Cell Aplasia
por: You, Xiaoe, et al.
Publicado: (2022) -
Roxadustat: Not just for anemia
por: Zhu, Xiaoyu, et al.
Publicado: (2022) -
Differential expression study of circular RNAs in exosomes from serum and urine in patients with idiopathic membranous nephropathy
por: Ma, Hualin, et al.
Publicado: (2019) -
Label-free quantitative proteomic analysis of serum exosomes in mice with thoracic aortic aneurysm
por: Xu, Jia, et al.
Publicado: (2023) -
Roxadustat for CKD-related Anemia in Non-dialysis Patients
por: Coyne, Daniel W., et al.
Publicado: (2020)